Company Profile

Arterra BioScience S.p.A. specializes in the research and development of ingredients and active ingredients. Net sales break down by source of income as follows:
- sales of cosmetic raw materials (84.3%);
- sales of research services (15.7%).
Italy accounts for 59.6% of net sales.


Source: Cofisem - Last Update: 2025-10-30

Key Executives
Chairwomen and Chief Executive Officer Maria Gabriella Colucci
Chief Financial Officer Gualtiero Ioimo
Head of Investor Relations Alexandra Fellermeier


Source: Cofisem - Last Update: 2025-10-30

Key Figures
Millenium 2024 2023 2022 2021 2020
Net sales 4,173 3,304 3,563 3,825 2,822
Consumed purchases 463 391 678 370 534
Labour costs 1,598 1,476 1,391 1,228 1,127
Operating profit 1,373 1,059 1,601 1,248 1,201
Income tax 365 226 383 164 91
Net income 1,337 1,076 1,414 1,110 1,109
Net income (Group share) 1,337 1,076 1,414 1,110 1,109
Fiscal year end 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards Local GAAP Local GAAP Local GAAP Local GAAP Local GAAP

Source: Cofisem - Last Update: 2025-10-30

Shareholder information
Free float 50.5 %
Maria Gabriella Colucci 27.9 %
Alberto Previtali 12.95 %
Intercos S.p.A. 8.65 %


Source: Cofisem - Last Update: 2025-10-30

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Arterra Bioscience


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.